Categories AlphaGraphs, Earnings, Health Care
Dentsply Sirona (XRAY) slips to a loss in Q1 but beats estimates
Dentsply Sirona Inc. (NASDAQ: XRAY) reported its preliminary financial results for the quarter ended March 31, 2020, on Friday before the bell. The results exceeded analysts’ expectations.
Dentsply Sirona slipped to a loss in the first quarter of 2020 from a profit last year, due to an Equipment & Instruments non-cash goodwill impairment and an intangible impairment. The Equipment & Instruments unit showed weakness in sales due to the ongoing COVID-19 impact on customer demand.
The dentists and customers reduced dental visits and procedures in response to the coronavirus pandemic. As a result of the uncertainty around the duration of the COVID-19 pandemic and its impact on the business, the company previously withdrew its 2020 guidance.
During the first quarter, the company bought back shares for a total cost of $140 million. In addition, the company paid $22.1 million in dividends resulting in a total of $162.1 million returned to shareholders during the first quarter of 2020.
Take a look at the rest of our Healthcare articles here
Most Popular
Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings
After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform
What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
